Docetaxel Trihydrate API Market to Reach USD 1.47 Billion by 2032 | Robust Demand Driven by Cancer Therapies – Dataintelo
Dataintelo forecasts that the global Docetaxel Trihydrate API Market is expected to reach USD 1.47 billion by 2032, growing at a CAGR of 5.9% from USD 875 million in 2023. The market's expansion is attributed to the rising global cancer burden, increasing demand for chemotherapy drugs, and growing investment in oncology R&D.
Docetaxel Trihydrate, a prominent anti-mitotic chemotherapy...
0 Commentarii
0 Distribuiri
1704 Views
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Português
Ελληνικά
Tiếng Việt